Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Ethan H. Mcilhenny

8 papers in the library · 633 citations · publishing 2009-2014

Papers

A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.

Drug Testing and Analysis January 1, 2012 Steven A. Barker, Ethan H. Mcilhenny, Rick J. Strassman 143 citations

Three indole alkaloids with varying psychedelic activity—DMT, bufotenine, and 5-MeO-DMT—have been reported as naturally occurring in humans. A critical review of 69 studies from 1955 to 2010 examined their detection in blood, urine, and cerebrospinal fluid. The review evaluates the methods and criteria used, highlighting strengths and weaknesses of past approaches. It notes shortcomings in existing data given recent findings and suggests future directions for research on these endogenous psychedelics.

Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca

Journal of Clinical Psychopharmacology October 15, 2011 Rafael G. Dos Santos, Marta Valle, José Carlos Bouso et al. 136 citations

Ayahuasca, an Amazonian psychotropic tea containing DMT and β-carboline alkaloids, produced moderate sympathomimetic effects, significant increases in prolactin and cortisol, and time-dependent changes in immune cell populations in a double-blind crossover trial with 10 healthy volunteers. Pupil dilation occurred with both ayahuasca and amphetamine, but ayahuasca’s effects were milder. Prolactin rose only after ayahuasca, while cortisol peaked higher with ayahuasca than with amphetamine. Lymphocyte subsets shifted similarly for both drugs: CD4 and CD3 percentages decreased, and natural killer cells increased, with maximum changes at 2 hours and return to baseline by 24 hours.

Metabolism and urinary disposition of N,N‐dimethyltryptamine after oral and smoked administration: a comparative study

Drug Testing and Analysis July 28, 2014 Jordi Riba, Ethan H. Mcilhenny, José Carlos Bouso et al. 96 citations

When N,N-dimethyltryptamine (DMT) is taken orally, it produces no psychedelic effects and no DMT appears in urine, because monoamine oxidase (MAO) breaks it down almost completely into indole-3-acetic acid (97% of recovered compounds). By contrast, smoking DMT yields full psychoactivity, with unmetabolized DMT and DMT-N-oxide rising to 10% and 28% of recovered compounds, while indole-3-acetic acid drops to 63%. An inverse relationship between the ratio of these metabolites and subjective effects indicates that smoking shifts metabolism from efficient MAO-dependent breakdown to less efficient CYP-dependent pathways, enabling psychoactivity.

Metabolism and disposition of N,N‐dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca

Drug Testing and Analysis April 19, 2012 Jordi Riba, Ethan H. Mcilhenny, Marta Valle et al. 91 citations

Ayahuasca, an Amazonian tea containing β-carboline alkaloids (harmine, harmaline, tetrahydroharmine) and the psychedelic DMT, is used worldwide, but its metabolism in humans had not been systematically studied. In 10 healthy men given freeze-dried ayahuasca (1.0 mg DMT/kg), less than 1% of DMT was excreted unchanged; about 50% was recovered as indole-3-acetic acid, 10% as DMT-N-oxide, and total DMT plus metabolites reached 68%. Harmala alkaloids were excreted as O-demethylated and conjugated metabolites, but recoveries varied from 9% to 65%. The findings indicate alternative metabolic routes for DMT beyond monoamine-oxidase and that O-demethylation plus conjugation is important but not the only pathway for harmala alkaloids.

Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry.

Journal of chromatography. A December 18, 2009 Ethan H. Mcilhenny, Kelly E Pipkin, Leanna J Standish et al. 58 citations

A new analytical method using direct injection and liquid chromatography-tandem mass spectrometry can simultaneously measure 11 psychoactive compounds in ayahuasca, a plant-based Amazonian beverage used in traditional medicine and religious ceremonies. The technique uses a deuterated internal standard for accurate quantitation and requires only simple dilution of samples up to 200-fold, avoiding complex extraction steps. It shows high specificity, low detection and quantitation limits, and appears to eliminate matrix effects. The method was tested on three different ayahuasca preparations and is expected to aid clinical, ethnobotanical, and forensic studies.

Methodology for determining major constituents of ayahuasca and their metabolites in blood.

Biomedical chromatography : BMC March 1, 2012 Ethan H. Mcilhenny, Jordi Riba, Manel J. Barbanoj et al. 57 citations

A new single analytical method can directly measure 14 major alkaloid components of ayahuasca, including known and potential metabolites of N,N-dimethyltryptamine and harmala alkaloids, in human blood plasma. The method uses 96-well plate protein precipitation and filtration followed by HPLC-ion trap-ion trap-mass spectrometry with heated electrospray ionization to reduce matrix effects. It provides adequate sensitivity, specificity, and reproducibility for clinical research, expanding the list of compounds that can be monitored after ayahuasca administration while simplifying the analysis compared to previous combined techniques.

Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.

Biomedical chromatography : BMC September 1, 2011 Ethan H. Mcilhenny, Jordi Riba, Manel J. Barbanoj et al. 51 citations

The primary metabolite of N,N-dimethyltryptamine (DMT) in humans after ayahuasca ingestion is the corresponding N-oxide, the first time this metabolite has been described in in vivo human studies. Very little DMT was detected in urine, despite monoamine oxidase inhibition by harmala alkaloids. The major harmala alkaloid excreted was tetrahydroharmine. A rapid, sensitive method using HPLC-electrospray ionization-selected reaction monitoring-tandem mass spectrometry was developed and applied to urine samples from three individuals administered ayahuasca, identifying and quantifying major constituents and metabolites. The protocol is suitable for toxicological and clinical research on ayahuasca.

Ayahuasca characterization, metabolism in humans, and relevance to endogenous N,N-dimethyltryptamines

June 8, 2012 Ethan H. Mcilhenny 1 citation

Ayahuasca is an Amazonian tea made from Banisteriopsis caapi, which contains beta-carboline alkaloids (harmine, harmaline, tetrahydroharmine) that inhibit monoamine oxidase, and often Psychotria viridis leaves rich in DMT, a psychoactive 5-HT2A agonist. A new liquid chromatography-tandem mass spectrometry method was developed to quantify the major alkaloids and their metabolites in ayahuasca, human blood, and urine. The main components in the tea were tetrahydroharmine and harmine, followed by DMT and harmaline. DMT's major metabolite was DMT-N-oxide, found in blood and urine but not in the tea. Less than 1% of the DMT dose appeared in urine or blood, despite MAO inhibition. Tetrahydroharmine was the main harmala alkaloid excreted. The method is suitable for human, ethnobotanical, and forensic studies.